Projects funded by the NCN

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

The role of kynurenine pathway in neurophatic pain in view of innovative treatment approaches

Call: SONATA 9 , Panel: NZ4

Principal investigator: dr Ewelina Joanna Rojewska

Instytut Farmakologii PAN

Functionalized amino acids - inibitors of GABA uptake with antianalgetic activity

Call: OPUS 8 , Panel: NZ7

Principal investigator: dr Paula Magdalena Zaręba

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Targeting peripheral cannabinoid receptors CB2 as a novel therapy to treat osteoarthritis

Call: OPUS 7 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

Synthesis, physicochemical and pharmacological properties of new amide derivatives of 3,3-disubstituted pyrrolidine-2,5-...

Call: OPUS 6 , Panel: NZ7

Principal investigator: prof. Jolanta Maria Obniska

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Endogenous enkephalinase inhibitors and their novel synthetic analogs as potential new therapeutics for the treatment of...

Call: OPUS 6 , Panel: NZ7

Principal investigator: dr hab. Jakub Jerzy Fichna

Uniwersytet Medyczny w Łodzi, Wydział Lekarski

Evaluation of pharmacological activity of new, nonselective gamma-aminobutyric acid (GABA) transport inhibitors in some ...

Call: OPUS 3 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Understanding the contribution of immunoproteasome activation to the neuropathic pain development.

Call: OPUS 25 , Panel: NZ7

Principal investigator: dr Natalia Eleonora Małek-Chudzik

Politechnika Wrocławska

The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic ...

Call: OPUS 23 , Panel: NZ7

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Cognitive impairment in chronic pain - CBD as the undervalued remedy.

Call: OPUS 22 , Panel: NZ7

Principal investigator: prof. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

New strategies in the pharmacotherapy of neuropathic pain based on modulation of the chemokine system and its influence ...

Call: OPUS 22 , Panel: NZ7

Principal investigator: prof. Joanna Gabriela Mika

Instytut Farmakologii PAN

Neurobiological mechanisms of migraine pain - role of opioid and NOP systems

Call: SONATA BIS 11 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Małgorzata Targowska-Duda

Uniwersytet Medyczny w Lublinie

Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Marta Kędziora

Instytut Farmakologii PAN

New 3-methoxypropanamide derivatives in search of effective substances for the treatment of neurological diseases - epil...

Call: PRELUDIUM 20 , Panel: NZ7

Principal investigator: Marcin Konrad Jakubiec

Uniwersytet Jagielloński, Collegium Medicum

Selective inhibitors of γ-aminobutyric acid (GABA) transporter subtype 3 (GAT3) as a new pharmacological tools and a cha...

Call: OPUS 21 , Panel: NZ7

Principal investigator: dr Dawid Marcin Panek

Uniwersytet Jagielloński, Collegium Medicum

Dual histamine H3 and sigma-1 receptor ligands as novel pharmacological tools in the treatment of central nervous system...

Call: SONATINA 4 , Panel: NZ7

Principal investigator: Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Pharmacological modulation of histamine H3 and H4 receptors - a new perspective in the treatment of neuropathic pain

Call: SONATA 15 , Panel: NZ7

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Endocannabinoid regulation of the motivational tone at the mesolimbic system driven by inflammation

Call: OPUS 18 , Panel: NZ7

Principal investigator: prof. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

Rational design and evaluation of functionally biased opioid agonists

Call: OPUS 16 , Panel: NZ7

Principal investigator: prof. Ryszard Przewłocki

Instytut Farmakologii PAN

New strategies in neuropathic pain pharmacotherapy based on the modulation of the functions of chemokine receptors CCR2 ...

Call: PRELUDIUM 15 , Panel: NZ7

Principal investigator: dr Klaudia Kwiatkowski

Instytut Farmakologii PAN

Opioid-induced analgesia and hyperalgesia in neuropathic pain - mechanisms and druggable targets

Call: OPUS 15 , Panel: NZ7

Principal investigator: prof. Barbara Elżbieta Przewłocka

Instytut Farmakologii PAN

Multifunctional ligands - TRPA1 channel antagonists and phosphodiesterases inhibitors as a new approach for the treatmen...

Call: OPUS 15 , Panel: NZ7

Principal investigator: prof. Grażyna Chłoń-Rzepa

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

Novel hybrid compounds derived from pyrrolidine-2,5-dione or imidazolidine-2,4-dione scaffold and their effect on centra...

Call: OPUS 13 , Panel: NZ7

Principal investigator: dr hab. Krzysztof Tomasz Kamiński

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

The role of synovial fibroblasts' activity in joint pain in osteoarthritis

Call: OPUS 12 , Panel: NZ7

Principal investigator: dr hab. Katarzyna Maria Starowicz-Bubak

Instytut Farmakologii PAN

Determination of the mechanisms and potential targets for neuropathic pain therapy by investigating pharmacological inte...

Call: PRELUDIUM 12 , Panel: NZ7

Principal investigator: Anna Piotrowska-Murzyn

Instytut Farmakologii PAN